Autopsy report · NCT03574649

QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Trial not initiated”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: ImmunityBio, Inc.
Sponsor type: Industry
Conditions: Non Small Cell Lung Cancer
Interventions: Nab-paclitaxel; Cisplatin; 5Fluorouracil; Cyclophosphamide; ETBX-011; ETBX-051
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.